Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer:XPD-Lys751Glnpolymorphism strikes back-Reference-Cited by-同舟云学术

Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer:XPD-Lys751Glnpolymorphism strikes back

Published:2013-03-04 Issue:4 Volume:133 Page:1016-1022
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Avan Amir¹,Pacetti Paola²,Reni Michele³,Milella Michele⁴,Vasile Enrico⁵,Mambrini Andrea²,Vaccaro Vanja⁴,Caponi Sara⁵,Cereda Stefano³,Peters Godefridus J.¹,Cantore Maurizio²,Giovannetti Elisa¹

Affiliation:

1. Department of Medical Oncology; VU University Medical Center; Amsterdam; The Netherlands

2. Department of Medical Oncology; Carrara Civic Hospital; Carrara; Italy

3. Department of Medical Oncology; San Raffaele Scientific Institute; Milan; Italy

4. Department of Medical Oncology A; Regina Elena National Cancer Institute; Rome; Italy

5. Unit Medical Oncology-2; Azienda-Ospedaliera-Universitaria Pisa; Pisa; Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

2. Definitive results of phase II trial of cisplatin, epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinoma;Reni;J Clin Oncol,2001

3. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial;Reni;Lancet Oncol,2005

4. Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding study;Reni;Cancer Invest,2007

5. Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma;Reni;Cancer Chemother Pharmacol,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells;International Journal of Radiation Oncology*Biology*Physics;2023-10

2. Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance;Drug Resistance Updates;2022-09

3. Biodegradable Ultrasmall-in-Nano Architectures Loaded with Cisplatin Prodrug in Combination with Ionizing Radiation Induces DNA Damage and Apoptosis in Pancreatic Ductal Adenocarcinoma;Cancers;2022-06-20

4. COL4A1, negatively regulated by XPD and miR-29a-3p, promotes cell proliferation, migration, invasion and epithelial–mesenchymal transition in liver cancer cells;Clinical and Translational Oncology;2021-04-23

5. The Association of Single-Nucleotide Polymorphism rs13181 in ERCC2 with Risk and Prognosis of Nasopharyngeal Carcinoma in an Endemic Chinese Population;Pharmacogenomics and Personalized Medicine;2021-03